<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">nnp</journal-id><journal-title-group><journal-title xml:lang="en">Neurology, Neuropsychiatry, Psychosomatics</journal-title><trans-title-group xml:lang="ru"><trans-title>Неврология, нейропсихиатрия, психосоматика</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-2711</issn><issn pub-type="epub">2310-1342</issn><publisher><publisher-name>"IMA-Press", LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/2074-2711-2023-6-48-55</article-id><article-id custom-type="elpub" pub-id-type="custom">nnp-2138</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL INVESTIGATIONS</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ И МЕТОДИКИ</subject></subj-group></article-categories><title-group><article-title>MRI assessment of different types of chronic demyelinating lesions in patients with multiple sclerosis using quantitative susceptibility mapping (QSM)</article-title><trans-title-group xml:lang="ru"><trans-title>МРТ-оценка различных типов хронических очагов демиелинизации у пациентов с рассеянным склерозом с помощью количественного картирования восприимчивости (QSM)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4604-7288</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Матросова</surname><given-names>М. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Matrosova</surname><given-names>M. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мария Сергеевна Матросова</p><p>125367, Москва, Волоколамское шоссе, 80</p></bio><bio xml:lang="en"><p>Maria Sergeevna Matrosova</p><p>80, Volokolamskoe Sh., Moscow 125367</p></bio><email xlink:type="simple">kmari-s@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1645-6526</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Брюхов</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Bryukhov</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>125367, Москва, Волоколамское шоссе, 80</p></bio><bio xml:lang="en"><p>80, Volokolamskoe Sh., Moscow 125367</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2676-452X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Попова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Popova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>117997, Москва, ул. Островитянова, 1; 127015, Москва, ул. Писцовая, 10</p></bio><bio xml:lang="en"><p>1, Ostrovityanova St., Moscow 117997; 310, Pistsovaya St., Moscow 127015</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9831-8970</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бельская</surname><given-names>Г. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Belskaya</surname><given-names>G. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>125367, Москва, Волоколамское шоссе, 80</p></bio><bio xml:lang="en"><p>80, Volokolamskoe Sh., Moscow 125367</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3820-4554</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кротенкова</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Krotenkova</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>125367, Москва, Волоколамское шоссе, 80</p></bio><bio xml:lang="en"><p>80, Volokolamskoe Sh., Moscow 125367</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ФГБНУ «Научный центр неврологии»<country>Россия</country></aff><aff xml:lang="en">Research Center of Neurology<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России; ГБУЗ «Городская клиническая больница № 24 Департамента здравоохранения г. Москвы»<country>Россия</country></aff><aff xml:lang="en">N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; City Clinical Hospital Twenty-Four, Moscow Healthcare Department<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>16</day><month>12</month><year>2023</year></pub-date><volume>15</volume><issue>6</issue><fpage>48</fpage><lpage>55</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Matrosova M.S., Bryukhov V.V., Popova E.V., Belskaya G.N., Krotenkova M.V., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Матросова М.С., Брюхов В.В., Попова Е.В., Бельская Г.Н., Кротенкова М.В.</copyright-holder><copyright-holder xml:lang="en">Matrosova M.S., Bryukhov V.V., Popova E.V., Belskaya G.N., Krotenkova M.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://nnp.ima-press.net/nnp/article/view/2138">https://nnp.ima-press.net/nnp/article/view/2138</self-uri><abstract><p>Histologically, chronic demyelinating lesions in multiple sclerosis (MS) have been shown to include inactive lesions that do not change over time and active or “smouldering" lesions that tend to enlarge over time and are surrounded by pro-inflammatory activated microglial cells that are loaded with iron. To identify “smouldering" foci of demyelination and assess the “latent” inflammatory process in the brain, MRI sequences sensitive to the detection of substances with paramagnetic properties, including iron, must be used. They include an innovative technique such as quantitative susceptibility mapping (QSM).</p><sec><title>Objective</title><p>Objective: to identify, using MRI different types of chronic demyelination foci in MS, based on iron distribution and the degree of damage (myelination) in their structure.</p></sec><sec><title>Material and methods</title><p>Material and methods. The patterns of iron distribution in demyelinating lesions in 90 MS patients were investigated using QSM. In addition, two lesions with different iron distribution patterns were randomly selected on the QSM map for each patient, in which the magnetic transfer ratio (MTR), indirectly reflecting the degree of myelination, was calculated. The identified changes were also compared with visualization of lesions in standard MRI modes (T1 MPRAGE, T2 FLAIR).</p></sec><sec><title>Results</title><p>Results. Despite the predominantly identical visualization in T2 FLAIR mode, chronic foci of demyelination show different patterns on the QSM maps, which is due to the peculiarities of iron distribution: some foci are not detected on QSM, while others are visualized either in the form of a homogeneous or a ring-shaped pattern. When comparing QSM data with MTR, it was found that MTR indicators were highest in non-visualized lesions (demyelination is minimal), while damage was most pronounced in lesions with ring-shaped iron distribution.</p></sec><sec><title>Conclusion</title><p>Conclusion. Different patterns of iron distribution in demyelination foci compared to the degree of myelination in these foci according to MTR were identified using QSM, which is of great importance for the evaluation of latent inflammation and the development of the neurodegenerative process in MS.</p></sec></abstract><trans-abstract xml:lang="ru"><p>Гистологически было показано, что среди хронических очагов демиелинизации при рассеянном склерозе (РС) выделяют неактивные очаги, не изменяющиеся со временем, и активные, или «тлеющие», которые имеют тенденцию увеличиваться с течением времени и окружены клетками провоспалительно активированной микроглии, нагруженной железом. Для выявления «тлеющих» очагов демиелинизации и оценки «скрытого» воспалительного процесса в головном мозге необходимо использовать МРТ-последовательности, чувствительные к выявлению веществ с парамагнитными свойствами, включая железо, к которым относится такая инновационная методика, как количественное картирование восприимчивости (quantitative susceptibility mapping, QSM).</p><p>Цель исследования – определить с помощью МРТ различные типы хронических очагов демиелинизации при РС на основе распределения в них железа и степени повреждения (миелинизации) в их структуре.</p><sec><title>Материал и методы</title><p>Материал и методы. При помощи QSM была проведена оценка паттернов распределения железа в очагах демиелинизации у 90 пациентов с РС. Также у каждого пациента на карте QSM было случайным образом выбрано по два очага с разными паттернами распределения железа, в которых был рассчитан коэффициент переноса намагниченности (magnetic transfer ratio, MTR), косвенно отражающий степень миелинизации, после чего был проведен анализ связи данных показателей. Выявленные изменения также были сопоставлены с визуализацией очагов в стандартных режимах МРТ (T1 MPRAGE, T2 FLAIR).</p></sec><sec><title>Результаты</title><p>Результаты. Несмотря на преимущественно одинаковую визуализацию в режиме T2 FLAIR, хронические очаги демиелинизации имеют различные паттерны на картах QSM, что обусловлено особенностями распределения железа: часть очагов не определяются на QSM, а другая часть – визуализируются в виде либо гомогенного, либо кольцевидного паттерна. При этом при сопоставлении данных QSM с MTR в невизуализируемых очагах показатели MTR оказались самыми высокими (демиелинизация минимальна), а в очагах с кольцевидным распределением железа, наоборот, повреждение было наиболее выражено.</p></sec><sec><title>Заключение</title><p>Заключение. С помощью QSM были выявлены различные паттерны распределения железа в очагах демиелинизации в сопоставлении со степенью миелинизации в них по данным MTR, что имеет большое значение для оценки скрытого воспаления и развития нейродегенеративного процесса при РС.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>рассеянный склероз</kwd><kwd>очаги с железосодержащим ободком</kwd><kwd>магнитно-резонансная томография</kwd><kwd>количественное картирование восприимчивости</kwd><kwd>QSM</kwd><kwd>МРТ с переносом намагниченности</kwd><kwd>MTR</kwd></kwd-group><kwd-group xml:lang="en"><kwd>multiple sclerosis</kwd><kwd>iron rim lesions</kwd><kwd>magnetic resonance imaging</kwd><kwd>quantitative susceptibility mapping</kwd><kwd>QSM</kwd><kwd>magnetic transfer imaging</kwd><kwd>MTR</kwd></kwd-group><funding-group xml:lang="ru"><funding-statement>Исследование не имело спонсорской поддержки</funding-statement></funding-group><funding-group xml:lang="en"><funding-statement>The investigation has not been sponsored</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018 Feb;17(2):162-73. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21.</mixed-citation><mixed-citation xml:lang="en">Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018 Feb;17(2):162-73. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Traboulsee A, Simon JH, Stone L, et al. Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis. AJNR Am J Neuroradiol. 2016 Mar;37(3):394-401. doi: 10.3174/ajnr.A4539. Epub 2015 Nov 12.</mixed-citation><mixed-citation xml:lang="en">Traboulsee A, Simon JH, Stone L, et al. Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis. AJNR Am J Neuroradiol. 2016 Mar;37(3):394-401. doi: 10.3174/ajnr.A4539. Epub 2015 Nov 12.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Filippi M, Rocca MA, Ciccarelli O, et al; MAGNIMS Study Group. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol. 2016 Mar;15(3):292-303. doi: 10.1016/S1474-4422(15)00393-2. Epub 2016 Jan 26.</mixed-citation><mixed-citation xml:lang="en">Filippi M, Rocca MA, Ciccarelli O, et al; MAGNIMS Study Group. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol. 2016 Mar;15(3):292-303. doi: 10.1016/S1474-4422(15)00393-2. Epub 2016 Jan 26.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Hemond CC, Bakshi R. Magnetic Resonance Imaging in Multiple Sclerosis. Cold Spring Harb Perspect Med. 2018 May 1;8(5):a028969. doi: 10.1101/cshperspect.a028969</mixed-citation><mixed-citation xml:lang="en">Hemond CC, Bakshi R. Magnetic Resonance Imaging in Multiple Sclerosis. Cold Spring Harb Perspect Med. 2018 May 1;8(5):a028969. doi: 10.1101/cshperspect.a028969</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Брюхов ВВ, Куликова СН, Кротенкова МВ и др. Современные методы визуализации в патогенезе рассеянного склероза. Анналы клинической и экспериментальной неврологии. 2013;(3):47-53.</mixed-citation><mixed-citation xml:lang="en">Bryukhov VV, Kulikova SN, Krotenkova MV, et al. State-of-the-art neuroimaging techniques in pathogenesis of multiple sclerosis. Annaly klinicheskoi i eksperimental'noi nevrologii = Annals of Clinical and Experimental Neurology. 2013;(3):47-53 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Frischer JM, Weigand SD, Guo Y, et al. Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque. Ann Neurol. 2015 Nov;78(5):710-21. doi: 10.1002/ana.24497. Epub 2015 Aug 24.</mixed-citation><mixed-citation xml:lang="en">Frischer JM, Weigand SD, Guo Y, et al. Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque. Ann Neurol. 2015 Nov;78(5):710-21. doi: 10.1002/ana.24497. Epub 2015 Aug 24.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Dal-Bianco A, Grabner G, Kronnerwetter C, et al. Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging. Acta Neuropathol. 2017 Jan;133(1):25-42. doi: 10.1007/s00401-016-1636-z. Epub 2016 Oct 27.</mixed-citation><mixed-citation xml:lang="en">Dal-Bianco A, Grabner G, Kronnerwetter C, et al. Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging. Acta Neuropathol. 2017 Jan;133(1):25-42. doi: 10.1007/s00401-016-1636-z. Epub 2016 Oct 27.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Harrison DM, Li X, Liu H, et al. Lesion Heterogeneity on High-Field Susceptibility MRI Is Associated with Multiple Sclerosis Severity. AJNR Am J Neuroradiol. 2016 Aug;37(8):1447-53. doi: 10.3174/ajnr.A4726. Epub 2016 Mar 3.</mixed-citation><mixed-citation xml:lang="en">Harrison DM, Li X, Liu H, et al. Lesion Heterogeneity on High-Field Susceptibility MRI Is Associated with Multiple Sclerosis Severity. AJNR Am J Neuroradiol. 2016 Aug;37(8):1447-53. doi: 10.3174/ajnr.A4726. Epub 2016 Mar 3.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Kular L, Ewing E, Needhamsen M, et al. DNA methylation changes in glial cells of the normal-appearing white matter in Multiple Sclerosis patients. Epigenetics. 2022 Nov;17(11):1311-30. doi: 10.1080/15592294.2021.2020436. Epub 2022 Jan 30.</mixed-citation><mixed-citation xml:lang="en">Kular L, Ewing E, Needhamsen M, et al. DNA methylation changes in glial cells of the normal-appearing white matter in Multiple Sclerosis patients. Epigenetics. 2022 Nov;17(11):1311-30. doi: 10.1080/15592294.2021.2020436. Epub 2022 Jan 30.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Yong VW. Microglia in multiple sclerosis: Protectors turn destroyers. Neuron. 2022 Nov 2;110(21):3534-48. doi: 10.1016/j.neuron.2022.06.023. Epub 2022 Jul 25.</mixed-citation><mixed-citation xml:lang="en">Yong VW. Microglia in multiple sclerosis: Protectors turn destroyers. Neuron. 2022 Nov 2;110(21):3534-48. doi: 10.1016/j.neuron.2022.06.023. Epub 2022 Jul 25.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Gillen KM, Mubarak M, Nguyen TD, Pitt D. Significance and In Vivo Detection of Iron-Laden Microglia in White Matter Multiple Sclerosis Lesions. Front Immunol. 2018 Feb 19;9:255. doi: 10.3389/fimmu.2018.00255</mixed-citation><mixed-citation xml:lang="en">Gillen KM, Mubarak M, Nguyen TD, Pitt D. Significance and In Vivo Detection of Iron-Laden Microglia in White Matter Multiple Sclerosis Lesions. Front Immunol. 2018 Feb 19;9:255. doi: 10.3389/fimmu.2018.00255</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Gillen KM, Mubarak M, Park C, et al. QSM is an imaging biomarker for chronic glial activation in multiple sclerosis lesions. Ann Clin Transl Neurol. 2021 Apr;8(4):877-86. doi: 10.1002/acn3.51338. Epub 2021 Mar 11.</mixed-citation><mixed-citation xml:lang="en">Gillen KM, Mubarak M, Park C, et al. QSM is an imaging biomarker for chronic glial activation in multiple sclerosis lesions. Ann Clin Transl Neurol. 2021 Apr;8(4):877-86. doi: 10.1002/acn3.51338. Epub 2021 Mar 11.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Rouault TA. Iron metabolism in the CNS: implications for neurodegenerative diseases. Nat Rev Neurosci. 2013 Aug;14(8):551-64. doi: 10.1038/nrn3453. Epub 2013 Jul 3.</mixed-citation><mixed-citation xml:lang="en">Rouault TA. Iron metabolism in the CNS: implications for neurodegenerative diseases. Nat Rev Neurosci. 2013 Aug;14(8):551-64. doi: 10.1038/nrn3453. Epub 2013 Jul 3.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Williams R, Buchheit CL, Berman NE, LeVine SM. Pathogenic implications of iron accumulation in multiple sclerosis. J Neurochem. 2012 Jan;120(1):7-25. doi: 10.1111/j.1471-4159.2011.07536.x. Epub 2011 Nov 11. Erratum in: J Neurochem. 2012 Apr;121(2):326.</mixed-citation><mixed-citation xml:lang="en">Williams R, Buchheit CL, Berman NE, LeVine SM. Pathogenic implications of iron accumulation in multiple sclerosis. J Neurochem. 2012 Jan;120(1):7-25. doi: 10.1111/j.1471-4159.2011.07536.x. Epub 2011 Nov 11. Erratum in: J Neurochem. 2012 Apr;121(2):326.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Y, Gauthier SA, Gupta A, et al. Quantitative Susceptibility Mapping and R2* Measured Changes during White Matter Lesion Development in Multiple Sclerosis: Myelin Breakdown, Myelin Debris Degradation and Removal, and Iron Accumulation. AJNR Am J Neuroradiol. 2016 Sep;37(9):1629-35. doi: 10.3174/ajnr.A4825. Epub 2016 Jun 2.</mixed-citation><mixed-citation xml:lang="en">Zhang Y, Gauthier SA, Gupta A, et al. Quantitative Susceptibility Mapping and R2* Measured Changes during White Matter Lesion Development in Multiple Sclerosis: Myelin Breakdown, Myelin Debris Degradation and Removal, and Iron Accumulation. AJNR Am J Neuroradiol. 2016 Sep;37(9):1629-35. doi: 10.3174/ajnr.A4825. Epub 2016 Jun 2.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Zivadinov R, Schweser F, Dwyer MG, Pol S. Detection of Monocyte/Macrophage and Microglia Activation in the TMEV Model of Chronic Demyelination Using USPIOEnhanced Ultrahigh-Field Imaging. J Neuroimaging. 2020 Nov;30(6):769-78. doi: 10.1111/jon.12768. Epub 2020 Aug 31.</mixed-citation><mixed-citation xml:lang="en">Zivadinov R, Schweser F, Dwyer MG, Pol S. Detection of Monocyte/Macrophage and Microglia Activation in the TMEV Model of Chronic Demyelination Using USPIOEnhanced Ultrahigh-Field Imaging. J Neuroimaging. 2020 Nov;30(6):769-78. doi: 10.1111/jon.12768. Epub 2020 Aug 31.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Hametner S, Wimmer I, Haider L, et al. Iron and neurodegeneration in the multiple sclerosis brain. Ann Neurol. 2013 Dec;74(6):848-61. doi: 10.1002/ana.23974. Epub 2013 Oct 7.</mixed-citation><mixed-citation xml:lang="en">Hametner S, Wimmer I, Haider L, et al. Iron and neurodegeneration in the multiple sclerosis brain. Ann Neurol. 2013 Dec;74(6):848-61. doi: 10.1002/ana.23974. Epub 2013 Oct 7.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Popescu BF, Frischer JM, Webb SM, et al. Pathogenic implications of distinct patterns of iron and zinc in chronic MS lesions. Acta Neuropathol. 2017 Jul;134(1):45-64. doi: 10.1007/s00401-017-1696-8. Epub 2017 Mar 22.</mixed-citation><mixed-citation xml:lang="en">Popescu BF, Frischer JM, Webb SM, et al. Pathogenic implications of distinct patterns of iron and zinc in chronic MS lesions. Acta Neuropathol. 2017 Jul;134(1):45-64. doi: 10.1007/s00401-017-1696-8. Epub 2017 Mar 22.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Kaunzner UW, Kang Y, Zhang S, et al. Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions. Brain. 2019 Jan 1;142(1):13345. doi: 10.1093/brain/awy296</mixed-citation><mixed-citation xml:lang="en">Kaunzner UW, Kang Y, Zhang S, et al. Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions. Brain. 2019 Jan 1;142(1):13345. doi: 10.1093/brain/awy296</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Haacke EM, Makki M, Ge Y, et al. Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging. 2009 Mar;29(3):537-44. doi: 10.1002/jmri.21676</mixed-citation><mixed-citation xml:lang="en">Haacke EM, Makki M, Ge Y, et al. Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging. 2009 Mar;29(3):537-44. doi: 10.1002/jmri.21676</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Liu C, Li W, Tong KA, et al. Susceptibilityweighted imaging and quantitative susceptibility mapping in the brain. J Magn Reson Imaging. 2015 Jul;42(1):23-41. doi: 10.1002/jmri.24768. Epub 2014 Oct 1.</mixed-citation><mixed-citation xml:lang="en">Liu C, Li W, Tong KA, et al. Susceptibilityweighted imaging and quantitative susceptibility mapping in the brain. J Magn Reson Imaging. 2015 Jul;42(1):23-41. doi: 10.1002/jmri.24768. Epub 2014 Oct 1.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Eskreis-Winkler S, Deh K, Gupta A, et al. Multiple sclerosis lesion geometry in quantitative susceptibility mapping (QSM) and phase imaging. J Magn Reson Imaging. 2015 Jul;42(1):224-9. doi: 10.1002/jmri.24745. Epub 2014 Aug 30.</mixed-citation><mixed-citation xml:lang="en">Eskreis-Winkler S, Deh K, Gupta A, et al. Multiple sclerosis lesion geometry in quantitative susceptibility mapping (QSM) and phase imaging. J Magn Reson Imaging. 2015 Jul;42(1):224-9. doi: 10.1002/jmri.24745. Epub 2014 Aug 30.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Y, Liu T. Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker. Magn Reson Med. 2015 Jan;73(1):82-101. doi: 10.1002/mrm.25358. Epub 2014 Jul 17.</mixed-citation><mixed-citation xml:lang="en">Wang Y, Liu T. Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker. Magn Reson Med. 2015 Jan;73(1):82-101. doi: 10.1002/mrm.25358. Epub 2014 Jul 17.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Filippi M, Rocca MA. Magnetic resonance imaging techniques to define and monitor tissue damage and repair in multiple sclerosis. J Neurol. 2007;254(1):155-62. doi: 10.1007/s00415-007-1010-0</mixed-citation><mixed-citation xml:lang="en">Filippi M, Rocca MA. Magnetic resonance imaging techniques to define and monitor tissue damage and repair in multiple sclerosis. J Neurol. 2007;254(1):155-62. doi: 10.1007/s00415-007-1010-0</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Fedorov A, Beichel R, Kalpathy-Cramer J, et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging. 2012 Nov;30(9):1323-41. doi: 10.1016/j.mri.2012.05.001. Epub 2012 Jul 6.</mixed-citation><mixed-citation xml:lang="en">Fedorov A, Beichel R, Kalpathy-Cramer J, et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging. 2012 Nov;30(9):1323-41. doi: 10.1016/j.mri.2012.05.001. Epub 2012 Jul 6.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Frischer JM, Bramow S, Dal-Bianco A, et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain. 2009 May;132(Pt 5):1175-89. doi: 10.1093/brain/awp070. Epub 2009 Mar 31.</mixed-citation><mixed-citation xml:lang="en">Frischer JM, Bramow S, Dal-Bianco A, et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain. 2009 May;132(Pt 5):1175-89. doi: 10.1093/brain/awp070. Epub 2009 Mar 31.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Mahad DH, Trapp BD, Lassmann H. Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol. 2015 Feb;14(2):183-93. doi: 10.1016/S14744422(14)70256-X</mixed-citation><mixed-citation xml:lang="en">Mahad DH, Trapp BD, Lassmann H. Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol. 2015 Feb;14(2):183-93. doi: 10.1016/S14744422(14)70256-X</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Weber CE, Wittayer M, Kraemer M, et al. Long-term dynamics of multiple sclerosis iron rim lesions. Mult Scler Relat Disord. 2022 Jan;57:103340. doi: 10.1016/j.msard.2021.103340. Epub 2021 Oct 18.</mixed-citation><mixed-citation xml:lang="en">Weber CE, Wittayer M, Kraemer M, et al. Long-term dynamics of multiple sclerosis iron rim lesions. Mult Scler Relat Disord. 2022 Jan;57:103340. doi: 10.1016/j.msard.2021.103340. Epub 2021 Oct 18.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Hnilicova P, Strbak O, Kolisek M, et al. Current Methods of Magnetic Resonance for Noninvasive Assessment of Molecular Aspects of Pathoetiology in Multiple Sclerosis. Int J Mol Sci. 2020 Aug 25;21(17):6117. doi: 10.3390/ijms21176117</mixed-citation><mixed-citation xml:lang="en">Hnilicova P, Strbak O, Kolisek M, et al. Current Methods of Magnetic Resonance for Noninvasive Assessment of Molecular Aspects of Pathoetiology in Multiple Sclerosis. Int J Mol Sci. 2020 Aug 25;21(17):6117. doi: 10.3390/ijms21176117</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Wisnieff C, Ramanan S, Olesik J, et al. Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: Interpreting positive susceptibility and the presence of iron. Magn Reson Med. 2015 Aug;74(2):564-70. doi: 10.1002/mrm.25420. Epub 2014 Aug 18.</mixed-citation><mixed-citation xml:lang="en">Wisnieff C, Ramanan S, Olesik J, et al. Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: Interpreting positive susceptibility and the presence of iron. Magn Reson Med. 2015 Aug;74(2):564-70. doi: 10.1002/mrm.25420. Epub 2014 Aug 18.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Deh K, Ponath GD, Molvi Z, et al. Magnetic susceptibility increases as diamagnetic molecules breakdown: Myelin digestion during multiple sclerosis lesion formation contributes to increase on QSM. J Magn Reson Imaging. 2018 Nov;48(5):1281-7. doi: 10.1002/jmri.25997. Epub 2018 Mar 8.</mixed-citation><mixed-citation xml:lang="en">Deh K, Ponath GD, Molvi Z, et al. Magnetic susceptibility increases as diamagnetic molecules breakdown: Myelin digestion during multiple sclerosis lesion formation contributes to increase on QSM. J Magn Reson Imaging. 2018 Nov;48(5):1281-7. doi: 10.1002/jmri.25997. Epub 2018 Mar 8.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Rahmanzadeh R, Galbusera R, Lu PJ, et al. A New Advanced MRI Biomarker for Remyelinated Lesions in Multiple Sclerosis. Ann Neurol. 2022 Sep;92(3):486-502. doi: 10.1002/ana.26441. Epub 2022 Jul 13.</mixed-citation><mixed-citation xml:lang="en">Rahmanzadeh R, Galbusera R, Lu PJ, et al. A New Advanced MRI Biomarker for Remyelinated Lesions in Multiple Sclerosis. Ann Neurol. 2022 Sep;92(3):486-502. doi: 10.1002/ana.26441. Epub 2022 Jul 13.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Orthmann-Murphy J, Call CL, Molina-Castro GC, et al. Remyelination alters the pattern of myelin in the cerebral cortex. Elife. 2020 May 27;9:e56621. doi: 10.7554/eLife.56621</mixed-citation><mixed-citation xml:lang="en">Orthmann-Murphy J, Call CL, Molina-Castro GC, et al. Remyelination alters the pattern of myelin in the cerebral cortex. Elife. 2020 May 27;9:e56621. doi: 10.7554/eLife.56621</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Y, Gauthier SA, Gupta A, et al. Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM). J Magn Reson Imaging. 2016 Aug;44(2):426-32. doi: 10.1002/jmri.25144. Epub 2016 Jan 22.</mixed-citation><mixed-citation xml:lang="en">Zhang Y, Gauthier SA, Gupta A, et al. Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM). J Magn Reson Imaging. 2016 Aug;44(2):426-32. doi: 10.1002/jmri.25144. Epub 2016 Jan 22.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
